InconclusiveClinical Trial2021
A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study
Classification Results
AI Classification
InconclusiveFine-tuned Classification
N/A